Working with ICER, or around it, on cost-effectiveness estimates - STAT

Working with ICER, or around it, on cost-effectiveness estimates - STAT

Working with ICER, or around it, on cost-effectiveness estimates

By SHEA MCCARTHY

ADOBE

An ICER announcement that it will review a new drug can make drugmakers and patient groups worry. There are ways to work with ICER — and alternatives to it.

READ MORE